HS Treatment Response Rates Continue to Improve with Secukinumab at Week 52
Newly released safety and efficacy data on Novartis’ secukinumab for hidradenitis suppurativa is published in The Lancet.
The Weekly Roundup: January 30-February 3
ICYMI, this week we had stories about adalimumab biosimilars, an expanded Banana Boat Hair & Scalp Sunscreen recall, what's trending in skin care for January 2023, and more.
Losing a Malpractice Case May Depend on Where You Live
This month's Legal Eagle column explores what information is required during an informed consent discussion.
10 Things I Wish My Patients Knew About Atopic Dermatitis
Atopic dermatitis is not a "one-size-fits-all" condition.
The Role We Play in Addressing Racial Disparity in Dermatology
It’s important to continuously look forward to our role in serving all patients and colleagues—especially those who are underrepresented.
The Mainstream Patient: February 2
This week's edition of the Mainstream Patient features stories about sensitive skin around the eyes, health risks of sharing razors, keratin shampoos for stronger hair, and more.
Pointers with Portela: Cosmetic Treatments With Matthew Elias, DO, FAAD
In this week’s Pointers with Dr Portela, the 208SkinDoc discusses botox and other cosmetic treatments with Matthew Elias, DO, FAAD.
Celebrating Patients With Skin of Color
Explore a collection of the best skin tips for patients with skin of color.
An Overview of Granulomatous Dermatitis
Granulomatous dermatitis includes a group of reactive dermatologic disorders characterized by distinct histopathological patterns, clinical manifestations, and associated diseases.
Discover Dermatology Times: January 2023
Learn more about what in-depth topics were covered in the January 2023 issue of Dermatology Times.
What's Trending in Skin Care: January 2023
Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are popular for the month of January.
Pemphigus: Updated Review and Emerging Therapies
Pemphigus is defined as a group of autoimmune, blistering disorders caused by circulating autoantibodies that bind to desmogleins, proteins that are vital to epidermal intercellular adhesion.
First Adalimumab Biosimilar, Adalimumab-atto, Available in the US
Christopher Bunick, MD, PhD, and Raj Chovatiya, MD, PhD, discuss the benefits of adalimumab-atto and the future of additional biosimilars in 2023.
Spesolimab Shows Significant Prevention of GPP Flares up to 48 Weeks
Preventing generalized pustular psoriasis may be possible based on recent data.
POLL: Which Adalimumab Biosimilar Will be Available First in 2023?
Click here to answer this week's poll.
Leukemia-Related Cutaneous Findings
This review will explore various leukemia-related cutaneous findings and discuss the diagnosis and management of these conditions.
Using Lasers to Treat Medical Problems
Suneel Chilukuri, MD, director of Cosmetic Surgery at Refresh Dermatology in Houston, Texas, previews his laser session and live injectable demonstration at Maui Derm Hawaii 2023.
The Weekly Roundup: January 16-20
ICYMI, this week we had stories about conference coverage from Winter Clinical Hawaii, generalized pustular psoriasis management, nutritional supplements for hair loss, and more.
The Mainstream Patient: January 19
This week's edition of the Mainstream Patient features stories about inclusive beauty tools, how to build a better body-care routine, 5 hydrating face washes, and more.
Say No to Nasal Tanning Sprays
Dermatologists have long warned tan seekers about the detrimental effects of ultraviolet exposure and tanning beds, strongly discouraging their use; nasal tanning sprays are no different.
Pointers with Portela: Interviewing Craig Kraffert, MD
In this week’s Pointers with Dr Portela, the 208SkinDoc interviews the founder of dermstore.com.
Drug Price Hikes Already Found in 2023
List prices of 450 medications have increased 5% overall at the beginning of 2023. More price hikes are expected.
Pointers with Portela: DermaMade Skincare
In this week’s Pointers with Dr Portela, the 208SkinDoc interviews Amy Brodsky, MD, about her new skin care line.
How Physicians Can Find the Right Attorney
As practices grow and become more intimately involved in patients’ complete health care — including regimens of sleep, nutrition, lifestyle, and even wearables — there is more room for lapses, errors or disagreements that pose questions suitable for lawyers.
Dermatology Drug Pipeline 2023
Breakthroughs and approvals we can expect in the coming year.
5 Simple Financial Tips for Dermatologists and Their Practices
Your practice’s finances are the key to long-term business success and understanding them doesn’t have to feel like a puzzle.
The Mainstream Patient: January 9
This week's edition of the Mainstream Patient features stories about PRP injections, sulfate-free shampoos for healthier hair, eczema creams for dry skin, and more.
Positive Topline Results Announced for Oral Orismilast for Treatment of Psoriasis
Union therapeutics is also developing the drug for treatment of atopic dermatitis and hidradenitis suppurativa.
The Weekly Roundup: January 2-6
ICYMI, this week we had stories about what to look forward to in 2023, psoriasis challenges, NDA submissions for berdazimer gel, and more.
Novan Submits NDA for Berdazimer Gel for the Treatment of Molluscum Contagiosum
Potential FDA approval is expected in the first quarter of 2024.
2 Clarke Drive Cranbury, NJ 08512